Regeneron Pharmaceuticals | 459.97 / +2.30% |
Date/Time | 03/05 / 21:33 |
Chg. / Chg.(%) | 10.36 / +2.30% |
Bid | 458.38 / 1 |
Ask | 460.12 / 1 |
Open | 454.12 |
Previous Close | 449.61 |
High | 463.58 |
Low | 449.72 |
Volume [USD] | 13,668,341.57 |
Volume [Units] | 67,539 |
Price fixings | 327 |
ISIN | US75886F1075 |
Security | REGN |
Exchange | Cboe US |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
NASDAQ | 460.1300 | ![]() |
889,782 |
Cboe US | 459.97 | ![]() |
67,539 |
IEX | 460.85 | ![]() |
54,037 |
TradeGate | 386.000 | ![]() |
937 |
Moscow | 34,061.00 | ![]() |
677 |
Frankfurt | 379.2000 | ![]() |
228 |
Vienna Globa.. | 379.65 | ![]() |
185 |
London Inter.. | 449.63 | ![]() |
151 |
Stuttgart | 383.300 | ![]() |
120 |
Xetra | 381.50 | ![]() |
67 |
München | 381.55 | ![]() |
42 |
gettex | 385.750 | ![]() |
29 |
Hamburg | 373.00 | ![]() |
0 |
Hannover | 373.00 | ![]() |
0 |
Düsseldorf | 387.00 | ![]() |
0 |
Berlin | 370.30 | ![]() |
0 |
Lang & Schwa.. | 385.45 | ![]() |
|
Mexico | 9,480.00 | ![]() |
85 |
News
- FDA accepts Dupixent® (dupilumab) for review in children with moderate-to-severe asthma
03/04/2021 / 07:00 - GlobeNewswire - EMA extends use advice for Regeneron COVID mix
02/26/2021 / 12:28 - TeleTrader - Ziopharm Oncology Provides Leadership and Corporate Updates; Reports Fourth Quarter and Full Year 2020 Financial Results
02/25/2021 / 22:05 - GlobeNewswire - Europe closes lower amid recovery uncertainties
02/25/2021 / 17:31 - TeleTrader - Regeneron: COVID cocktail has clear efficacy
02/25/2021 / 14:13 - TeleTrader